Is Regeneron Pharmaceuticals, Inc. (REGN) a Buy, Sell, or Hold?
Regeneron Pharmaceuticals, Inc.
NASDAQ:REGN
$653.0992 USD
-$3.02 (-0.46%)
- Volume
- 13.51K
- Average Volume
- 1.01M
- Market Capitalization
- $67.28B
- P/E Ratio
- 15.36
- Dividend Yield
- 0.56%
- Price Target
- $839.50
- Year High
- $821.11
- Year Low
- $541.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.08
- Current Ratio
- $3.57
Analyst Rating
Buy
4 Rating Score
UPSIDE/DOWNSIDE
-22.2% DOWNSIDE
$839.50 Price Target
UPSIDE/DOWNSIDE HIGH
-34.4% DOWNSIDE
$995.00 Price Target High
UPSIDE/DOWNSIDE LOW
1.9% UPSIDE
$641.00 Price Target Low
INSIDER TRADING
Shares
$- Last Quarter
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Piper Sandler | Biren Amin | $854 | $662.88 | 2026-07-09 07:13 AM | 28.8% |
| Morgan Stanley | Terence Flynn | $730 | $676.23 | 2026-07-08 07:39 AM | 8.0% |
| Canaccord Genuity | John Newman | $875 | $629.68 | 2026-05-19 06:43 AM | 39.0% |
| Wolfe Research | Alexandria Hammond | $860 | $629.36 | 2026-05-18 02:48 PM | 36.6% |